The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Sarafem     N-methyl-3-phenyl-3-[4...

Synonyms: Bioxetin, Deproxin, Digassim, Felicium, Fluctine, ...
This record was replaced with 3386.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Prozac


Psychiatry related information on Prozac


High impact information on Prozac


Chemical compound and disease context of Prozac


Biological context of Prozac


Anatomical context of Prozac


Associations of Prozac with other chemical compounds


Gene context of Prozac


Analytical, diagnostic and therapeutic context of Prozac


  1. Severe neutropenia associated with fluoxetine hydrochloride. Vilinsky, F.D., Lubin, A. Ann. Intern. Med. (1997) [Pubmed]
  2. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Grubb, B.P., Samoil, D., Kosinski, D., Wolfe, D., Lorton, M., Madu, E. Am. J. Med. (1994) [Pubmed]
  3. Treatment of fibrositis with fluoxetine hydrochloride (Prozac). Geller, S.A. Am. J. Med. (1989) [Pubmed]
  4. Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats. Lin, M.T. J. Physiol. (Lond.) (1978) [Pubmed]
  5. Possible association between fluoxetine hydrochloride and colic in an infant. Lester, B.M., Cucca, J., Andreozzi, L., Flanagan, P., Oh, W. Journal of the American Academy of Child and Adolescent Psychiatry. (1993) [Pubmed]
  6. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Tollefson, G.D., Rampey, A.H., Potvin, J.H., Jenike, M.A., Rush, A.J., kominguez, R.A., Koran, L.M., Shear, M.K., Goodman, W., Genduso, L.A. Arch. Gen. Psychiatry (1994) [Pubmed]
  7. Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial. Cook, J.W., Spring, B., McChargue, D.E., Borrelli, B., Hitsman, B., Niaura, R., Keuthen, N.J., Kristeller, J. Psychopharmacology (Berl.) (2004) [Pubmed]
  8. Effects of Lilly 110140 (flouxetine) on self-stimulation behavior in the dorsal and ventral regions of the lateral hypothalamus in the mouse. Cazala, P. Psychopharmacology (Berl.) (1980) [Pubmed]
  9. Prozac and crime: who is the victim? Mason, S.E. The American journal of orthopsychiatry. (2002) [Pubmed]
  10. Questions & answers. What is Symbyax, the new drug being marketed for the treatment of bipolar depression. Miller, M.C. The Harvard mental health letter / from Harvard Medical School. (2004) [Pubmed]
  11. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). Pastuszak, A., Schick-Boschetto, B., Zuber, C., Feldkamp, M., Pinelli, M., Sihn, S., Donnenfeld, A., McCormack, M., Leen-Mitchell, M., Woodland, C. JAMA (1993) [Pubmed]
  12. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Fu, C.H., Williams, S.C., Cleare, A.J., Brammer, M.J., Walsh, N.D., Kim, J., Andrew, C.M., Pich, E.M., Williams, P.M., Reed, L.J., Mitterschiffthaler, M.T., Suckling, J., Bullmore, E.T. Arch. Gen. Psychiatry (2004) [Pubmed]
  13. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Baxter, L.R., Schwartz, J.M., Bergman, K.S., Szuba, M.P., Guze, B.H., Mazziotta, J.C., Alazraki, A., Selin, C.E., Ferng, H.K., Munford, P. Arch. Gen. Psychiatry (1992) [Pubmed]
  14. Elevated serum digoxin level associated with coadministered fluoxetine. Leibovitz, A., Bilchinsky, T., Gil, I., Habot, B. Arch. Intern. Med. (1998) [Pubmed]
  15. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Roy, M., David, N., Cueva, M., Giorgetti, M. Biol. Psychiatry (2007) [Pubmed]
  16. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Pigott, T.A., Pato, M.T., Bernstein, S.E., Grover, G.N., Hill, J.L., Tolliver, T.J., Murphy, D.L. Arch. Gen. Psychiatry (1990) [Pubmed]
  17. Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells. Choi, J.S., Choi, B.H., Ahn, H.S., Kim, M.J., Rhie, D.J., Yoon, S.H., Min, d.o. .S., Jo, Y.H., Kim, M.S., Sung, K.W., Hahn, S.J. Biochem. Pharmacol. (2003) [Pubmed]
  18. Potentiation of morphine hyperthermia in cats by pimozide and fluoxetine hydrochloride. French, E.D., Vasquez, S.A., George, R. Eur. J. Pharmacol. (1978) [Pubmed]
  19. Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake. Messing, R.B., Phebus, L., Fisher, L.A., Lytle, L.D. Psychopharmacology communications. (1975) [Pubmed]
  20. Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor. Robertson, D.W., Jones, N.D., Swartzendruber, J.K., Yang, K.S., Wong, D.T. J. Med. Chem. (1988) [Pubmed]
  21. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Cantor, J.M., Binik, Y.M., Pfaus, J.G. Psychopharmacology (Berl.) (1999) [Pubmed]
  22. Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. Nahon, E., Israelson, A., Abu-Hamad, S., Varda, S.B. FEBS Lett. (2005) [Pubmed]
  23. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine. Wong, D.T., Bymaster, F.P., Horng, J.S., Molloy, B.B. J. Pharmacol. Exp. Ther. (1975) [Pubmed]
  24. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Spencer, M.J. Pediatrics (1993) [Pubmed]
  25. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. Ungvari, Z., Pacher, P., Koller, A. J. Cardiovasc. Pharmacol. (2000) [Pubmed]
  26. Effect of Prozac on whole cell ionic currents in lens and corneal epithelia. Rae, J.L., Rich, A., Zamudio, A.C., Candia, O.A. Am. J. Physiol. (1995) [Pubmed]
  27. Expression of CRABP-I and -II in human epidermal cells. Alteration of relative protein amounts is linked to the state of differentiation. Siegenthaler, G., Tomatis, I., Chatellard-Gruaz, D., Jaconi, S., Eriksson, U., Saurat, J.H. Biochem. J. (1992) [Pubmed]
  28. Fluoxetine inhibits K(+) transport pathways (K(+) efflux, Na(+)-K(+)-2Cl(-) cotransport, and Na(+) pump) underlying volume regulation in corneal endothelial cells. Hara, E., Reinach, P.S., Wen, Q., Iserovich, P., Fischbarg, J. J. Membr. Biol. (1999) [Pubmed]
  29. Adsorption of fluoxetine HCl by activated charcoal. Cooney, D.O., Thomason, R. Journal of pharmaceutical sciences. (1997) [Pubmed]
  30. Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. Westenberger, B.J., Ellison, C.D., Fussner, A.S., Jenney, S., Kolinski, R.E., Lipe, T.G., Lyon, R.C., Moore, T.W., Revelle, L.K., Smith, A.P., Spencer, J.A., Story, K.D., Toler, D.Y., Wokovich, A.M., Buhse, L.F. International journal of pharmaceutics. (2005) [Pubmed]
  31. Elevation of serum prolactin levels after the inhibition of serotonin uptake. Morgan, W.W., Herbert, D.C. Endocrinology (1978) [Pubmed]
  32. Treatment of ADHD with fluoxetine: a preliminary trial. Barrickman, L., Noyes, R., Kuperman, S., Schumacher, E., Verda, M. Journal of the American Academy of Child and Adolescent Psychiatry. (1991) [Pubmed]
  33. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study. Mukherjee, J., Yang, Z.Y. Eur. J. Pharmacol. (1997) [Pubmed]
  34. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women. Urban, R.J., Veldhuis, J.D. Am. J. Obstet. Gynecol. (1991) [Pubmed]
  35. Freud, Prozac, and the human condition. Khouzam, H.R. Canadian journal of psychiatry. Revue canadienne de psychiatrie. (1996) [Pubmed]
  36. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. van Minnen, A., Hoogduin, K.A., Keijsers, G.P., Hellenbrand, I., Hendriks, G.J. Arch. Gen. Psychiatry (2003) [Pubmed]
  37. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Suckow, R.F., Zhang, M.F., Cooper, T.B. Clin. Chem. (1992) [Pubmed]
  38. Nonaqueous capillary electrophoresis-electrospray- mass spectrometry for the analysis of fluoxetine and its related compounds. Cherkaoui, S., Veuthey, J.L. Electrophoresis (2002) [Pubmed]
  39. Myocardial protection in the hypertrophied right ventricle. Cusimano, R.J., Ashe, K.A., Chin, I.D., Chi, P., Abel, J.G., Lichtenstein, S.V., Salerno, T.A. Ann. Thorac. Surg. (1991) [Pubmed]
WikiGenes - Universities